Job Not Found

AdaptHealth (NASDAQ: AHCO) extends debt maturities and lowers interest costs. Filing Impact Filing Sentiment Rhea-AI Filing summary. AdaptHealth Corp. entered into a new senior secured credit facility totaling $1.1 billion, replacing its prior credit arrangements and extending its debt maturity profile. The package includes a $325 million Term Loan A, a $325 million delayed draw term loan, and a $450 million revolving credit facility. Proceeds from the new term loan repaid the existing term loan and prior credit agreement, while the delayed draw facility is intended to redeem the 6.125% Senior Notes due 2028, lowering interest expense. The facility, maturing in April 2031, features lower SOFR-based pricing tied to leverage covenants and is supported by recent credit rating upgrades. The company states the transaction does not change its full-year 2026 guidance. Positive. * The new $1.1 billion senior secured credit facility extends AdaptHealth's debt maturity to April 2031, reduces SOFR-based pricing margins, and is expected to lower weighted average cost of debt by at least 25 bps after redemption of the 6.125% Senior Notes due 2028. Negative. Insights. Refinancing extends debt maturities to 2031 and modestly lowers borrowing costs. AdaptHealth has arranged a $1.1 billion senior secured credit facility, combining a term loan, delayed draw term loan, and revolver. This replaces its prior term loan and smaller revolver, consolidating bank debt under a single agreement with standardized covenants. The company plans to use the $325 million delayed draw term loan to redeem its 6.125% Senior Notes due 2028, once callable at par, which should reduce interest expense. The facility matures in April 2031, roughly two years later than the prior structure, easing near-term refinancing risk. Pricing is now indexed to the Consolidated Total Leverage Ratio, with SOFR margins as low as 1.125%. Management estimates at least a 25 bps reduction in weighted average cost of debt after note redemption. Recent rating upgrades by S&P and Moody's likely supported these terms, and the company indicates its 2026 guidance remains unchanged, framing this as a balance-sheet optimization rather than a shift in operating outlook. 8-K event classification. 5 items: 1.01, 1.02, 2.03, 7.01, 9.01 Key figures. Total new credit facility: $1.1 billion Term Loan A size: $325 million Delayed Draw Term Loan: $325 million +5 more Key terms. Delayed Draw Term Loan, Revolving loan commitments, Consolidated Total Leverage Ratio, Term SOFR, +2 more 04/13/2026 - 08:11 AM Faq. What did AdaptHealth (AHCO) announce regarding its new credit facility? AdaptHealth closed a new $1.1 billion senior secured credit facility. It includes a $325 million Term Loan A, a $325 million Delayed Draw Term Loan, and a $450 million revolving credit facility, replacing its prior term loan and smaller revolver. How will AdaptHealth use the proceeds from the new Term Loan A and Delayed Draw Facility? The $325 million Term Loan A was used to fully repay the company's existing term loan and prior credit agreement. The $325 million Delayed Draw Facility is intended to redeem the 6.125% Senior Notes due 2028 once they become callable at par in August 2026. How does the new AdaptHealth credit facility affect debt maturities? The new senior secured credit facility matures in April 2031, extending AdaptHealth's debt maturity profile by roughly two years. This longer runway reduces near-term refinancing risk and supports the company's ability to pursue its strategic and operational priorities. What interest rate terms apply to AdaptHealth's new credit facility? Borrowings can be based on a base rate or Term SOFR, plus an Applicable Margin. For SOFR loans, the margin ranges from 1.125% to 2.000% per year, determined by the Consolidated Total Leverage Ratio, replacing the company's prior, higher pricing grid. Will AdaptHealth's new financing change its 2026 financial guidance? AdaptHealth states the new $1.1 billion credit facility is not expected to affect its full-year 2026 guidance. Management frames the transaction as a refinancing that improves terms and flexibility, rather than a change in the company's underlying operating outlook. What role did credit rating upgrades play in AdaptHealth's new facility? Recent rating upgrades by S&P Global Ratings and Moody's Ratings recognized improved performance and a stronger balance sheet. AdaptHealth believes these upgrades, plus consistent free cash flow, helped secure a lower pricing grid and favorable terms on the new credit facility. Filing exhibits & attachments. 2 documents Press releases.

AdaptHealth Corp., a US provider of home medical equipment and services, has closed a $1.1 billion senior secured credit facility, consisting of a $325 million term loan, a $325 million delayed draw facility and a $450 million revolving credit line. The new facility replaces the company's existing debt arrangements. The refinancing extends AdaptHealth's debt maturity to April 2031, approximately two years beyond the previous facility, whilst reducing borrowing costs. The interest rate pricing grid has been lowered, with the lowest tier falling from 1.50% to 1.125% over SOFR. The company expects its weighted average cost of debt to decrease by at least 25 basis points once its 6.125% senior notes due 2028 are redeemed. The improved terms follow recent credit rating upgrades from S&P Global Ratings and Moody's Ratings.